Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

14 July 2020: Clinical Research

Long Non-Coding RNA THOR Enhances the Stem Cell-Like Traits of Triple-Negative Breast Cancer Cells Through Activating β-Catenin Signaling

Binbin Wang 1ABCE* , Qiang Ye 2BCD* , Chuantao Zou 1AEG*

DOI: 10.12659/MSM.923507

Med Sci Monit 2020; 26:e923507

Figure 4 THOR directly binds to β-catenin mRNA, enhances its mRNA stability and expression. (A–C) The mRNA and protein levels of Sox9 and β-catenin were examined in TNBC cells with THOR knockdown or not. (D) The in vitro RNA-RNA interaction was performed to examine the THOR-β-catenin RNA interaction in TNBC cells. (E) RIP assay on THOR level in RNA pulled down by anti-β-catenin. (F, G) Analysis on the mRNA stability of β-catenin was performed in TNBC cells with THOR knockdown or not. (H) Luciferase reporter analysis on the TOPflash and FOPflash in MDA-MB-453 cells with THOR knockdown or not. (I) The expression of the downstream effectors of β-catenin was detected in TNBC cells with THOR knockdown or not. ** P<0.01. mRNA – messenger RNA; TNBC – triple negative breast cancer; RIP – RNA immunoprecipitation.

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750